Wed., Sept. 15, 2021, Virtual Program: WHAT ARE THE CHALLENGES PRESENTED BY YOUR CHRONIC HCV PATIENTS?
Posted over 2 years ago
This announcement has 1 attachment:
You are cordially invited to attend an EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg) tablets virtual program titled “WHAT ARE THE CHALLENGES PRESENTED BY YOUR CHRONIC HCV PATIENTS?”. Please open the attached invitation to find out more about the event.
Wednesday, September 15, 2021 6:00 PM Pacific
ALEX LAPASARAN, NP Nurse Practitioner, Las Vegas Gastroenterology
GILEAD CONTACT INFORMATION Paul Krisfalusi at (702) 278-9429 or via email at paul.krisfalusi@gilead.com
To register, please visit the following link: